The Directorate of Revenue Intelligence arrested three persons, including the Managing Director of a pharmaceutical company based at Vijayawada, for alleged illegal export of Ephedrine tablets, a controlled substance notified under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
According to Directorate of Revenue Intelligence here today, the arrested persons have been remanded to judicial custody by the Metropolitan Sessions Judge, Hyderabad.
Asthma
It''s a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it
Advertisement
The arrested persons had 'conspired in procurement and illegal export of around 2500 cartons each containing one lakh tablets valued at Rs 10 crore in the international market', the release said.
The examination of the Laptop maintained by the Managing Director of Venkat Pharma Limited, having its factory at Vijayawada and registered office at Hyderabad, revealed that they have 'exported the Ephedrine tables in the guise of their regular pharmaceutical formulations'.
The Managing Director procured the said tablets from local dealers through another accused based at Vijayawada.
The former business development head of the pharmaceutical company was also arrested who had visited some Africian countries and liaised with customers for distribution of these tablets, the release added.
Source: PTI News
Advertisement
The Managing Director procured the said tablets from local dealers through another accused based at Vijayawada.
The former business development head of the pharmaceutical company was also arrested who had visited some Africian countries and liaised with customers for distribution of these tablets, the release added.
Source: PTI News
Advertisement
Advertisement
|
Advertisement
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.